In contrast, Hanash et al. demonstrated that recipient innate lymphoid cell (ILC)-derived IL-22 was able to enhance regeneration of IL-22R-expressing ISCs in a more acute major mismatch GVHD model (76). Here, IL22 is linked to graft versus host disease.